Properties (89)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
nan
|
| gptkbp:annualVisitors |
$10 million
|
| gptkbp:awards |
Best New Company 2020
|
| gptkbp:brand |
Growing Presence
|
| gptkbp:businessModel |
Sustained Growth
Innovative_Solutions |
| gptkbp:CEO |
gptkb:Robert_A._McCarthy
|
| gptkbp:challenges |
Market Competition
|
| gptkbp:clinicalTrials |
Ongoing
Phase II Trials Phase I, II, III Published Studies Positive Results |
| gptkbp:collaborations |
Academic Institutions
|
| gptkbp:community |
Significant Contributions
|
| gptkbp:community_service |
Improved Access
|
| gptkbp:communityEngagement |
Health Initiatives
|
| gptkbp:communityPartnerships |
Local Organizations
Global_Collaborations |
| gptkbp:communitySupport |
Local Health Programs
|
| gptkbp:customerBase |
Healthcare_Providers
|
| gptkbp:customerFeedback |
Incorporated into Development
|
| gptkbp:employees |
50-100
Comprehensive Packages High Levels |
| gptkbp:financialPerformance |
Positive Growth
Strong Results |
| gptkbp:financials |
Publicly Traded
Venture_Capital |
| gptkbp:focus |
Drug Development
|
| gptkbp:founded |
2018
|
| gptkbp:founder |
gptkb:Robert_A._McCarthy
|
| gptkbp:futurePlans |
Expand Internationally
|
| gptkbp:hasResearchInterest |
Conducted Regularly
|
| gptkbp:headquarters |
gptkb:New_Jersey
|
| gptkbp:healthcare |
Leading_Edge_Solutions
|
| https://www.w3.org/2000/01/rdf-schema#label |
N4 Pharmaceuticals, Inc.
|
| gptkbp:innovation |
Encourages Creativity
|
| gptkbp:investmentFocus |
Institutional Investors
Transparent Communication Research_and_Development |
| gptkbp:leadership |
Experienced_Team
|
| gptkbp:localGovernment |
Strong Practices
|
| gptkbp:market |
gptkb:North_America
Competitive Advantage $100 million Adapted to Changes New_Regions New_Drug_in_2021 |
| gptkbp:marketingStrategy |
High Standards
Plans in Place |
| gptkbp:marketSegment |
Targeted Marketing
|
| gptkbp:mission |
Improve_Patient_Outcomes
|
| gptkbp:network |
Industry Events
|
| gptkbp:partnerships |
Emerging Companies
Various_Biotech_Firms |
| gptkbp:patentCitation |
Multiple_Patents_Filed
|
| gptkbp:productLine |
Diverse_Pipeline
|
| gptkbp:productQuality |
High Standards
|
| gptkbp:products |
Rigorous Testing
Innovative Approaches N4P-001 Unique Formulations |
| gptkbp:regulatoryCompliance |
Meets Standards
FDA_Approved Navigated_Successfully |
| gptkbp:research |
Secured Grants
|
| gptkbp:researchAreas |
Chronic Diseases
|
| gptkbp:researchFocus |
Neurological Disorders
|
| gptkbp:researchInterest |
gptkb:Global_Partnerships
Received |
| gptkbp:riskManagement |
Proactive Strategies
|
| gptkbp:socialResponsibility |
Health Education
|
| gptkbp:stakeholders |
Active Participation
|
| gptkbp:stockSymbol |
N4P
|
| gptkbp:strategicGoals |
Expand Portfolio
|
| gptkbp:subsidiary |
nan
|
| gptkbp:succeededBy |
Patient_Outcomes
|
| gptkbp:supplyChain |
Efficient Processes
|
| gptkbp:sustainabilityInitiatives |
Green Practices
|
| gptkbp:teamAchievements |
Inclusive Environment
|
| gptkbp:technology |
Advanced_Technologies
Advanced_Systems |
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:training |
Ongoing Programs
|
| gptkbp:type |
Public Company
|
| gptkbp:vision |
Innovative Therapies
|
| gptkbp:website |
www.n4pharma.com
|